Results 11 to 20 of about 754,068 (197)

'The risks of playing it safe': a prospective longitudinal study of response to reward in the adolescent offspring of depressed parents [PDF]

open access: yes, 2013
BACKGROUND Alterations in reward processing may represent an early vulnerability factor for the development of depressive disorder. Depression in adults is associated with reward hyposensitivity and diminished reward seeking may also be a feature of ...
A. Rawal   +6 more
core   +1 more source

Comorbid depressive disorders in ADHD. the role of ADHD severity, subtypes and familial psychiatric disorders [PDF]

open access: yes, 2014
ObjectiveaaTo evaluate the presence of Major Depressive Disorder (MDD) and Dysthymic Disorder (DD) in a sample of Italian children with Attention Deficit Hyperactivity Disorder (ADHD) and to explore specific features of comorbid depressive disorders in ...
Andriola E   +6 more
core   +1 more source

Ethiopathogenesis of Depressive Disorders [PDF]

open access: yesClinical Practice & Epidemiology in Mental Health, 2014
Etiology of depressive disorders is still unknown. Several factors are involved in its pathophysiology such as neurotransmitters and neuroendocrine alterations, genetics, life events and their appraisal. Some of these components are strictly linked.
Pasquini, M., Berardelli, I., Biondi, M.
openaire   +3 more sources

Depressive disorders.

open access: yesAmerican family physician, 2004
[no abstract available]
Geddes J. R.   +7 more
openaire   +9 more sources

Morbidity in Depressive Disorders [PDF]

open access: yesPsychotherapy and Psychosomatics, 2017
Levels of residual morbidity in mood disorder patients followed up long-term under community conditions of treatment are remarkably high [1] . Both unipolar major depressive disorder (MDD) and bipolar disorder (BD) patients were ill 40–50% of follow-up time; in BD patients, three-quarters of that residual morbidity was depressive [1] .
Baldessarini, Ross J.   +6 more
openaire   +3 more sources

Serum level of soluble interleukin 6 receptor is a useful biomarker for identification of treatment‐resistant major depressive disorder

open access: yesNeuropsychopharmacology Reports, 2020
Aim A substantial proportion of major depressive disorder patients are treatment‐resistant to antidepressant therapy, who require augmentation drugs, or other treatments including electroconvulsive therapy or transcranial magnetic stimulation ...
Katsuhiko Yamasaki   +2 more
doaj   +1 more source

Features of minor depressive disorder subtypes in conditions of COVID-19 pandemic

open access: yesIndian Journal of Psychiatry, 2020
Background: The continuous research on minor depressive disorder is one of the pressing issues in the context of the COVID-19 pandemic. We studied the features of minor depressive disorder subtypes in conditions of the COVID-19 pandemic.
Shokhrukh Sultanov   +4 more
doaj   +1 more source

Maintenance deep transcranial magnetic stimulation sessions are associated with reduced depressive relapses in patients with unipolar or bipolar depression [PDF]

open access: yes, 2015
Introduction: Deep transcranial magnetic stimulation (dTMS) is a new form of TMS allowing safe stimulation of deep brain regions. The objective of this preliminary study was to assess the role of dTMS maintenance sessions in protecting patients with ...
ANGELETTI, Gloria   +11 more
core   +2 more sources

Depressive disorder at the household level: prevalence and correlates of depressive symptoms among household members

open access: yesGlobal Health Action, 2023
Background Globally, an estimated five percent of adults have major depressive disorder. However, little is known about the relationship between these individuals’ depressive symptoms and their household members’ mental health and well-being.
Kondwani Mpinga   +13 more
doaj   +1 more source

Evaluation of olfactory bulb volume and olfactory sulcus depth in patients with panic disorder and depressive disorder: An MRI study

open access: yesIndian Journal of Psychiatry, 2022
Background: Although some studies have shown decreases in the olfactory bulb (OB) volume and olfactory function in depressive disorder, there are no studies investigating OB volume in patients with panic disorder.
Gül Ferda Cengiz   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy